Cognitive Behavioral Therapy for Insomnia and Depression Among Menopausal Women
Depression, Insomnia, Cognitive Behavioral Therapy
About this trial
This is an interventional treatment trial for Depression
Eligibility Criteria
Inclusion Criteria: Women with depression (BDI-II score of 14-63) Women aged between 40 and 55 years old, menopausal (12 consecutive months without menses) Women are willing to provide written informed consent to participate in the study. Women who have the ability to read and write Arabic language. Women who report wake after sleep onset (wakefulness in the middle of the night after falling asleep) of an hour or more on ≥ 3 nights per week and met criteria for Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) (American Psychiatric Association, 2013) insomnia disorder with onset or exacerbation during the peri- or postmenopausal period per clinical interview with the researcher. Women who have a total score of >5 on the Pittsburgh Sleep Quality Index (PSQI), which indicates poor sleep, and a total score of >7 on the Insomnia Severity Index (ISI), which indicates insomnia. Exclusion Criteria: Women who are currently under any type of psychotherapy or have a previous experience of Cognitive Behavioral Therapy. Women who have a history of neuropsychiatric illness, cancer, chemotherapy, and sudden stress in the previous 6 months (due to unfortunate events in the family) or have a severe or uncontrolled physical illness. Women who are clearly diagnosed as having sleep disorders or obstructive sleep apnea and had taken sleeping medications. Women who are on hormonal replacement therapy or cancer therapy or drugs such as tricyclic antidepressants, selective serotonin reuptake inhibitors, sedatives, and other hormones; and those who had undergone hysterectomy with oophorectomy.
Sites / Locations
- Beni-Suef University
- Mansoura University
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Experimental Group
Control Group
The Cognitive Behavioral Therapy group received seven weekly face-to-face sleep group Cognitive Behavioral Therapy sessions lasting for 50-60 min. The Cognitive Behavioral Therapy program was developed by the research team after reviewing the literature and consulting with experts. Cognitive Behavioral Therapy was held in a lecture hall located in the PPFK branch office before individual counseling was initiated.
The study participants of the control arm were interviewed separately and were given general health advice.